B
9.12
0.29 (3.28%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Biohaven Ltd. | 看跌 | 看跌 |
AIStockmoo 评分
0.0
| 分析师共识 | -0.5 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -4.0 |
| 平均 | 0.00 |
|
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 11.96% |
| 机构持股比例 | 90.75% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Suvretta Capital Management, Llc | 30 Sep 2025 | 5,620,271 |
| Bellevue Group Ag | 30 Sep 2025 | 2,802,853 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 26.00 (Morgan Stanley, 185.09%) | 购买 |
| 中 | 14.00 (53.51%) | |
| 低 | 9.00 (RBC Capital, -1.32%) | 保留 |
| 9.00 (Bernstein, -1.32%) | 保留 | |
| 平均值 | 14.00 (53.51%) | |
| 总计 | 5 购买, 4 保留 | |
| 平均价格@调整类型 | 8.92 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 03 Dec 2025 | 11.00 (20.61%) | 保留 | 8.83 |
| UBS | 26 Nov 2025 | 11.00 (20.61%) | 保留 | 9.48 |
| 16 Sep 2025 | 26.00 (185.09%) | 购买 | 13.49 | |
| JP Morgan | 20 Nov 2025 | 15.00 (64.47%) | 购买 | 9.63 |
| BTIG | 18 Nov 2025 | 16.00 (75.44%) | 购买 | 9.45 |
| 06 Nov 2025 | 16.00 (75.44%) | 购买 | 8.53 | |
| Morgan Stanley | 18 Nov 2025 | 26.00 (185.09%) | 购买 | 9.45 |
| Citigroup | 13 Nov 2025 | 14.00 (53.51%) | 购买 | 8.08 |
| 17 Sep 2025 | 28.00 (207.02%) | 购买 | 14.70 | |
| Bernstein | 06 Nov 2025 | 9.00 (-1.32%) | 保留 | 8.53 |
| RBC Capital | 06 Nov 2025 | 9.00 (-1.32%) | 保留 | 8.53 |
| TD Cowen | 05 Nov 2025 | 15.00 (64.47%) | 购买 | 8.34 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合